Hepatitis News

The nucleoside analogue entecavir achieves a high response rate and progressive decline in liver stiffness in patients with chronic hepatitis B, according to results from the first study in 'real-life' clinical practice reported at the Annual Meeting of the American Association for the Study of Liver Diseases .

New York, NY -- XOMA Ltd. ; Biostar Pharmaceuticals, Inc. ; Idenix Pharmaceuticals, Inc.

Main Category: Liver Disease / Hepatitis Also Included In: Clinical Trials / Drug Trials Article Date: 03 Nov 2009 A methacetin breath test that can be performed quickly and noninvasively has been proven to accurately predict survival in patients with viral hepatitis and may be used as an adjunctive tool to MELD.

BARACLUDE Demonstrated Greater Antiviral Efficacy Compared To Adefovir In New Study Of Chronic Hepatitis B Patients With Cirrhosis Bristol-Myers Squibb today announced 48-week data from an ongoing study of chronic hepatitis B patients with decompensated cirrhosis, in which BARACLUDE demonstrated greater viral suppression compared to adefovir.

The hepatitis B vaccine - given to protect against infection by a virus that can cause severe liver damage and cancer - may protect for more than two decades, according to a new study.

Schering-Plough Reports Potent Antiviral Activity With Narlaprevir , an Investigational, Once-Daily Protease Inhibitor for Hepatitis C Interim results of Phase IIa NEXT-I study presented at American Association for the Study of Liver Diseases Annual Meeting BOSTON, Nov.

Presented: Tuesday, November 3, 2009, 8:00 am Eastern Time in Boston, MA ALEXANDRIA, Va.

PRINCETON, N.J. & SEATTLE - Bristol-Myers Squibb Company and ZymoGenetics, Inc. today presented final results from a Phase 1b clinical trial of PEG-Interferon lambda administered with ribavirin in relapsed and treatment-nave hepatitis C virus patients.

Oct 31, 2009 - Gilead Sciences, Inc. today announced the presentation of three-year open label data from two pivotal Phase III clinical trials, Studies 102 and 103, evaluating the safety and efficacy of once-daily Viread among adult patients with chronic hepatitis B virus infection.

Schering-Plough Corp. said its experimental hepatitis C drug boceprevir helped eliminate the virus in about half of patients who did not respond to standard treatments.

A Henry Ford Hospital study found that hepatitis B does not increase the risk for pancreatic cancer a ' and that only age is a contributing factor.

VICTORIAN health authorities have renewed their warnings over links between semi-dried tomatoes and an outbreak of hepatitis A following a further 23 cases of the infectious disease diagnosed in the past week.

Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood, as well as a low rate of relapse, according to a Henry Ford Hospital study.

Researchers in New York City are reporting their work uncovering a new epidemic of hepatitis C virus infection among men-who-have-sex-with-men who have HIV infection.

A Henry Ford Hospital study found that hepatitis B does not increase the risk for pancreatic cancer - and that only age is a contributing factor.

Main Category: Melanoma / Skin Cancer Also Included In: Pharma Industry / Biotech Industry Clinical Trials / Drug Trials Schering-Plough Corp.

Yesterday I introduced the bi-partisan Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009, in order to address a silent, deadly, national Hepatitis B and Hepatitis C epidemic impacting America.

Main Category: Liver Disease / Hepatitis Also Included In: Transplants / Organ Donations Although women with chronic hepatitis C virus infection are at lower risk for developing cirrhosis, researchers who compared outcomes for men and women after having liver transplantation found that women have a significantly increased risk of overall graft loss ...

Main Category: Liver Disease / Hepatitis Also Included In: Cancer / Oncology Article Date: 28 Oct 2009 Distinguished transplant and cancer surgeon, Alan Hemming, MD, has been recruited to the University of California, School of Medicine to launch a multidisciplinary center for the treatment of advanced liver disease at the UC San Diego Medical ...

Mongolia's ruling party has nominated the current foreign minister and one of the country's wealthiest men to be the new prime minister of the impoverished but resource-rich nation.